Peroxymonophosphate

Peroxymonophosphate

SCHEMBL1207235

O=P([O-])([O-])OO.O=P([O-])([O-])OO.O=P([O-])([O-])OO.[Fe+3].[Fe+3]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
CA1 P00915 2/20 0.40
CA4 P22748 2/20 0.40
CA5A P35218 2/20 0.40
CA5B Q9Y2D0 2/20 0.40
SLC34A1 Q06495 1/20 0.40
KDM4E B2RXH2 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Peroxymonophosphate SCHEMBL3629906 0.96 LMNA (0.39) LMNACA1CA4CA5ACA5B
Peroxymonophosphate SCHEMBL4534353 0.96
Peroxymonophosphate SCHEMBL5792455 0.92
Peroxymonophosphate SCHEMBL4665163 0.92 LMNA (0.41) LMNACA1CA4CA5ACA5B
Peroxymonophosphate SCHEMBL9451019 0.92 LMNA (0.41) LMNACA1CA4CA5ACA5B
Peroxymonophosphate SCHEMBL25249573 0.92 LMNA (0.41) LMNACA1CA4CA5ACA5B
Peroxymonophosphate SCHEMBL10457435 0.92
Peroxymonophosphate SCHEMBL924472 0.92
Peroxymonophosphate SCHEMBL9451046 0.92 LMNA (0.41) LMNACA1CA4CA5ACA5B
Peroxymonophosphate SCHEMBL5790488 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117430105-B Method for preparing lithium iron manganese phosphate from hydroxyl ferric phosphate and application of lithium iron manganese phosphate 湖北融通高科先进材料集团股份有限公司 2026-05-22 CN claimed
CN-117430106-B Method for preparing lithium iron phosphate from iron hydroxy phosphate and ferrous oxalate and application 湖北融通高科先进材料集团股份有限公司 2026-05-12 CN claimed
CN-122013289-A Green plate and strip dephosphorization process using pulse current 北京众联鑫旺科技有限公司 2026-05-12 CN claimed
CN-120004235-A Preparation method and application of ferric phosphate material 湖北融通高科先进材料集团股份有限公司 2025-05-16 CN claimed
CN-116355616-B Heavy metal pollution repair material and preparation method and application thereof 中南大学 2025-04-08 CN claimed
CN-119706762-A Iron hydroxy phosphate and preparation method and application thereof 天津大学 2025-03-28 CN claimed
CN-119528106-A Method for preparing high-compaction lithium iron phosphate material from hydroxyl ferric phosphate and application of high-compaction lithium iron phosphate material 湖北融通高科先进材料集团股份有限公司 2025-02-28 CN claimed
CN-119461305-A Method for preparing lithium iron phosphate by recycling waste lithium iron phosphate material 湖北融通高科先进材料集团股份有限公司 2025-02-18 CN claimed
CN-119101357-A Hypophosphite flame-retardant PPS composite material and preparation method and application thereof 金发科技股份有限公司 2024-12-10 CN claimed
CN-118954455-A Method for recycling all components of waste lithium manganese iron phosphate anode material 广东光华科技股份有限公司 2024-11-15 CN claimed
US-20100065787-A1 METHOD FOR SYNTHESIS OF CARBON-COATED REDOX MATERIALS WITH CONTROLLED SIZE HYDRO-QUEBEC (CA) 2010-03-18 US claimed
US-7601318-B2 Mixed metal phosphates, sulfates or silicates crosslinked with carbon for use in primary or secondary electrochemical generators (batteries), supercapacity generators and in the area of modulation systems for electrochromic light. HYDRO-QUEBEC (CA) 2009-10-13 US claimed
WO-2009002801-A1 METHOD OF REMOVING PHOSPHORUS FROM WASTEWATER I. KRUGER INC. (US) 2008-12-31 WO claimed
US-20080314830-A1 Adding iron or aluminum salt to the wastewater resulting in the precipitation of ferric or aluminum hydroxyphosphate which includes phosphorus adsorption sites adn which bcome part of the sludge; circulating sludge to increase adsorbers concentration to remove more phosphorus; dephosphorization I. KRUGER INC. (US) 2008-12-25 US claimed
US-7285260-B2 Primary or secondary electrochemical generators (batteries), supercapacity generators and in the area of modulation systems for electrochromic light HYDRO QUEBEC (CA) 2007-10-23 US claimed
US-7148386-B2 Oxidizing an aromatic hydroxy compound with an oxidizing agent in a biphasic solvent system in the presence of a transition metal hydroxy phosphate catalyst to produce a corresponding hydroquinone compound GENERAL ELECTRIC COMPANY (US) 2006-12-12 US claimed
WO-2006015036-A2 PROCESSES FOR PREPARING BENZOQUINONES AND HYDROQUINONES GENERAL ELECTRIC COMPANY (US) 2006-02-09 WO claimed
US-20060025634-A1 Processes for preparing benzoquinones and hydroquinones SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2006-02-02 US claimed
US-20040086445-A1 Primary or secondary electrochemical generators (batteries), supercapacity generators and in the area of modulation systems for electrochromic light WORLDWISE, INC. 2004-05-06 US claimed
US-20040033360-A1 Mixed metal phosphates, sulfates or silicates crosslinked with carbon for use in primary or secondary electrochemical generators (batteries), supercapacity generators and in the area of modulation systems for electrochromic light. AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT 2004-02-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025634-A1 Processes for preparing benzoquinones and hydroquinones HAO2, HAAO, HPD LMNA 2557/4885CA1 2788/4885CA4 1820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.